Citation Impact
2 from Science/Nature 61 standout
Citing Papers
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
2023 Standout
Targeting CDK4 and CDK6 in cancer
2022 Standout
Works of Laura Lam being referenced
3300 A phase 1b/2 study of ribociclib (LEE011; CDK4/6 inhibitor) in combination with binimetinib (MEK162; MEK inhibitor) in patients with NRAS-mutant melanoma
2015
Author Peers
| Author | PFM | Molecular Biology | Genetics | Oncology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Laura Lam | 75 | 116 | 49 | 94 | 13 | 206 | |
| Guido Cordoni | 27 | 10 | 494 | ||||
| Christie L. Carroll | 161 | 30 | 17 | 32 | 21 | 1.5k | |
| Kathleen A. Hilliard | 4 | 419 | 45 | 23 | 11 | 1.6k | |
| Robert W. Curley | 34 | 1148 | 18 | 82 | 92 | 1.7k | |
| R. Knott | 4 | 5 | 165 |
All Works
Loading papers...